Production (Stage)
CME Group Inc.
CME
$284.07
$2.070.73%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.66% | 4.60% | 17.73% | 11.20% | 1.34% |
| Total Other Revenue | 6.22% | 27.85% | 29.68% | 37.70% | 38.39% |
| Total Revenue | 10.35% | 5.98% | 18.47% | 12.69% | 3.22% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 10.35% | 5.98% | 18.47% | 12.69% | 3.22% |
| SG&A Expenses | 1.95% | 3.89% | 10.37% | 3.52% | 1.68% |
| Depreciation & Amortization | -3.28% | -3.36% | -4.98% | -5.71% | -3.83% |
| Other Operating Expenses | 0.97% | 10.58% | 17.21% | 4.16% | -6.15% |
| Total Operating Expenses | 1.03% | 3.52% | 8.27% | 1.98% | 0.10% |
| Operating Income | 15.46% | 7.51% | 24.87% | 19.32% | 5.02% |
| Income Before Tax | 11.80% | 9.01% | 20.79% | 13.59% | -3.76% |
| Income Tax Expenses | 11.77% | 15.99% | 17.85% | 13.61% | -5.46% |
| Earnings from Continuing Operations | 11.81% | 7.37% | 21.67% | 13.58% | -3.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.81% | 7.37% | 21.67% | 13.58% | -3.24% |
| EBIT | 15.46% | 7.51% | 24.87% | 19.32% | 5.02% |
| EBITDA | 13.93% | 6.54% | 21.97% | 16.91% | 4.24% |
| EPS Basic | 11.71% | 7.27% | 21.54% | 13.46% | -3.33% |
| Normalized Basic EPS | 11.69% | 7.98% | 20.67% | 13.46% | -3.85% |
| EPS Diluted | 11.49% | 7.19% | 21.36% | 13.13% | -3.29% |
| Normalized Diluted EPS | 11.68% | 7.99% | 20.67% | 13.45% | -3.90% |
| Average Basic Shares Outstanding | 0.10% | 0.10% | 0.11% | 0.11% | 0.09% |
| Average Diluted Shares Outstanding | 0.11% | 0.10% | 0.10% | 0.12% | 0.14% |
| Dividend Per Share | 8.70% | 4.55% | 4.55% | 4.55% | 4.55% |
| Payout Ratio | -0.01% | -0.03% | -0.14% | -0.08% | 0.18% |